Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Shares Issued (2021 - 2025)

Cardio Diagnostics Holdings' Shares Issued history spans 5 years, with the latest figure at $116646.0 for Q3 2025.

  • For Q3 2025, Shares Issued fell 94.17% year-over-year to $116646.0; the TTM value through Sep 2025 reached $11.1 million, up 120.25%, while the annual FY2024 figure was $12.5 million, 3117.17% up from the prior year.
  • Shares Issued for Q3 2025 was $116646.0 at Cardio Diagnostics Holdings, down from $3.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $65.0 million in Q4 2021 and bottomed at -$1.0 in Q4 2022.
  • The 5-year median for Shares Issued is $1.2 million (2022), against an average of $6.9 million.
  • The largest YoY upside for Shares Issued was 4392.0% in 2022 against a maximum downside of 100.0% in 2022.
  • A 5-year view of Shares Issued shows it stood at $65.0 million in 2021, then crashed by 100.0% to -$1.0 in 2022, then surged by 39000100.0% to $390000.0 in 2023, then skyrocketed by 1829.1% to $7.5 million in 2024, then plummeted by 98.45% to $116646.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Shares Issued are $116646.0 (Q3 2025), $3.4 million (Q1 2025), and $7.5 million (Q4 2024).